Track the CELYAD ONCOLOGY share price and the full insider trade history of the company, a listed issuer based in Belgium. Shares are listed on BE BE, under the supervision of FSMA. Operating in the Health Care sector, CELYAD ONCOLOGY has recorded 6 reports. Market capitalisation: €13.3m. The latest transaction was disclosed on 28 November 2024 (Other). Among the most active insiders: Kane Matthew. All data is openly available.
6
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Fundamental score
Ranked 4,395 of 26,102 companies
68.8
score / 100
Value
49
Quality
89
FCF yld-69%
Earn yld8.4%
EV/EBITDA9.3x
ROE56%
Gross mgn62%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.